Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Albrecht

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Toxins|August 8, 2020
Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and LiteratureSara Samadzadeh, Beyza Ürer, Raphaela Brauns, et al.
Experimental Brain Research|December 29, 2020
Impact of the number of conditioning pulses on motor cortex excitability: a transcranial magnetic stimulation studyPetyo Nikolov, Johanna V Zimmermann, Shady S Hassan, et al.
Acta Neurologica Scandinavica|July 4, 2019
Factors associated with headache in intravenous immunoglobulin treatment for neurological diseasesJonas Graf, Jens Ingwersen, Klaudia Lepka, et al.
Cancers|June 2, 2021
A Hybrid In Silico and Tumor-on-a-Chip Approach to Model Targeted Protein Behavior in 3D MicroenvironmentsValentina Palacio-Castañeda, Simon Dumas, Philipp Albrecht, et al.
Toxins|July 28, 2023
Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot StudyHarald Hefter, Isabelle Schomaecker, Max Schomaecker, et al.
Frontiers in Neurology|March 6, 2026
Mind the gap: a German case study on the discrepancy between geographic accessibility and real-world utilization of botulinum toxin therapyTristan Koelsche, Robin Jansen, Lars Masanneck, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 6, 2021
Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1Jonas Graf, Jan Mares, Michael Barnett, et al.
Clinical & Experimental Ophthalmology|January 31, 2017
Alterations of the outer retina in non-arteritic anterior ischaemic optic neuropathy detected using spectral-domain optical coherence tomographyPhilipp Ackermann, Maike Brachert, Philipp Albrecht, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2021
Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2Jonas Graf, Jan Mares, Michael Barnett, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2021
Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosisSteffen Pfeuffer, Laura Kerschke, Tobias Ruck, et al.
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Toxins|August 8, 2020
Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and LiteratureSara Samadzadeh, Beyza Ürer, Raphaela Brauns, et al.
Experimental Brain Research|December 29, 2020
Impact of the number of conditioning pulses on motor cortex excitability: a transcranial magnetic stimulation studyPetyo Nikolov, Johanna V Zimmermann, Shady S Hassan, et al.
Acta Neurologica Scandinavica|July 4, 2019
Factors associated with headache in intravenous immunoglobulin treatment for neurological diseasesJonas Graf, Jens Ingwersen, Klaudia Lepka, et al.
Cancers|June 2, 2021
A Hybrid In Silico and Tumor-on-a-Chip Approach to Model Targeted Protein Behavior in 3D MicroenvironmentsValentina Palacio-Castañeda, Simon Dumas, Philipp Albrecht, et al.
Toxins|July 28, 2023
Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot StudyHarald Hefter, Isabelle Schomaecker, Max Schomaecker, et al.
Frontiers in Neurology|March 6, 2026
Mind the gap: a German case study on the discrepancy between geographic accessibility and real-world utilization of botulinum toxin therapyTristan Koelsche, Robin Jansen, Lars Masanneck, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 6, 2021
Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1Jonas Graf, Jan Mares, Michael Barnett, et al.
Clinical & Experimental Ophthalmology|January 31, 2017
Alterations of the outer retina in non-arteritic anterior ischaemic optic neuropathy detected using spectral-domain optical coherence tomographyPhilipp Ackermann, Maike Brachert, Philipp Albrecht, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2021
Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2Jonas Graf, Jan Mares, Michael Barnett, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2021
Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosisSteffen Pfeuffer, Laura Kerschke, Tobias Ruck, et al.
Pageof 17